Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 18.63%121.56B | 12.82%555.84B | 13.79%183.53B | 12.85%140.13B | 16.98%129.72B | 6.36%102.48B | 11.52%492.69B | 4.89%161.29B | 15.40%124.17B | 10.88%110.88B |
Cost of revenue | 16.89%102.22B | 12.51%460.54B | 14.59%149.58B | 10.62%113.15B | 17.31%110.37B | 6.08%87.45B | 10.74%409.33B | 3.01%130.53B | 11.69%102.29B | 11.49%94.08B |
Gross profit | 28.75%19.34B | 14.33%95.3B | 10.37%33.95B | 23.29%26.98B | 15.14%19.35B | 7.99%15.02B | 15.54%83.36B | 13.70%30.76B | 36.61%21.88B | 7.59%16.81B |
Operating expense | 10.21%20.22B | 12.13%70.97B | 15.81%19.14B | 14.67%18.58B | -5.23%14.91B | 23.67%18.35B | 11.82%63.3B | 17.16%16.52B | 34.96%16.21B | 4.85%15.73B |
Staff costs | ---- | -0.81%28.74B | ---- | ---- | ---- | ---- | 6.15%28.98B | ---- | ---- | ---- |
Selling and administrative expenses | ---- | 5.67%10.36B | ---- | ---- | ---- | ---- | 14.52%9.8B | ---- | ---- | ---- |
-Selling and marketing expense | ---- | -2.88%7.39B | ---- | ---- | ---- | ---- | 6.86%7.61B | ---- | ---- | ---- |
-General and administrative expense | ---- | 35.28%2.97B | ---- | ---- | ---- | ---- | 52.36%2.2B | ---- | ---- | ---- |
Research and development costs | ---- | 31.06%11.25B | ---- | ---- | ---- | ---- | 39.85%8.58B | ---- | ---- | ---- |
Rent and land expenses | ---- | 28.29%2.93B | ---- | ---- | ---- | ---- | 0.62%2.29B | ---- | ---- | ---- |
Other operating expenses | ---- | 29.64%17.69B | ---- | ---- | ---- | ---- | 10.64%13.65B | ---- | ---- | ---- |
Operating profit | 73.59%-878M | 21.27%24.33B | 4.07%14.82B | 47.90%8.4B | 314.18%4.44B | -259.74%-3.32B | 29.05%20.06B | 9.94%14.24B | 41.54%5.68B | 74.59%1.07B |
Net non-operating interest income (expenses) | 69.44%61M | 111.85%50M | -144.00%-61M | 12.62%-90M | 226.92%165M | 121.95%36M | 38.03%-422M | 87.56%-25M | 54.63%-103M | 3.70%-130M |
Non-operating interest income | 49.74%283M | 146.99%904M | 20.40%242M | 104.71%174M | 564.44%299M | 440.00%189M | 185.94%366M | 1,446.15%201M | 93.18%85M | 40.63%45M |
Non-operating interest expense | 45.10%222M | 8.38%854M | 34.07%303M | 40.43%264M | -23.43%134M | -23.12%153M | -2.60%788M | 5.61%226M | -30.63%188M | 4.79%175M |
Net investment income | -43.32%263M | 3,551.28%1.35B | 273.45%1.69B | -136.20%-366M | 61.87%-440M | 233.33%464M | 95.57%-39M | 44.41%452M | 245.89%1.01B | -310.68%-1.15B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 740M | 0 | ||||||||
Income from associates and other participating interests | -223.31%-1.08B | 298.82%1.69B | 74.89%397M | 166.67%256M | 165.00%159M | 2,087.50%875M | 62.69%423M | -30.58%227M | 137.94%96M | -74.25%60M |
Special income (charges) | -326.01%-1.56B | -298.17%-1.31B | -93.14%70M | 677.53%692M | -468.54%-328M | 1.02B | ||||
Less:Other special charges | ---- | 208.03%1.12B | 6,700.00%858M | ---70M | ---- | ---- | ---1.03B | ---13M | ---- | ---- |
Less:Write off | ---- | 31.38%448M | ---- | ---- | ---- | ---- | -90.76%341M | ---- | ---- | ---- |
Other non-operating income (expenses) | -126.98%-429M | -14.42%-2.5B | -86.98%-1.08B | -139.50%-958M | 68.02%-276M | 45.38%-189M | 20.37%-2.19B | 63.05%-576M | -9.89%-400M | -107.95%-863M |
Income before tax | 3.51%-2.06B | 29.98%24.08B | 8.66%15.19B | 0.11%7.31B | 466.67%3.72B | -22.75%-2.14B | 56.03%18.53B | 14.57%13.98B | 195.31%7.3B | -619.15%-1.01B |
Income tax | 452.48%712M | 71.86%5B | 129.50%2.02B | 10.87%1.72B | 517.72%1.46B | -184.17%-202M | -26.52%2.91B | -69.86%878M | 98.85%1.56B | -10.23%237M |
Net income | -43.41%-2.78B | 22.19%19.08B | 0.57%13.18B | -2.82%5.58B | 280.18%2.25B | 2.37%-1.94B | 97.36%15.62B | 41.04%13.1B | 240.14%5.75B | -208.89%-1.25B |
Net income continuous operations | -43.36%-2.77B | 22.18%19.08B | 0.56%13.18B | -2.80%5.58B | 280.18%2.25B | 2.32%-1.94B | 97.35%15.62B | 41.04%13.1B | 239.94%5.75B | -208.89%-1.25B |
Noncontrolling interests | 179.17%38M | 110.53%80M | 403.70%136M | -165.79%-25M | 126.56%17M | -229.73%-48M | 192.31%38M | 145.45%27M | 442.86%38M | -900.00%-64M |
Net income attributable to the company | -49.15%-2.81B | 21.97%19B | -0.27%13.04B | -1.73%5.61B | 288.53%2.24B | 6.63%-1.89B | 97.20%15.58B | 40.91%13.08B | 239.70%5.71B | -187.86%-1.19B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -49.15%-2.81B | 21.97%19B | -0.27%13.04B | -1.73%5.61B | 288.53%2.24B | 6.63%-1.89B | 97.20%15.58B | 40.91%13.08B | 239.70%5.71B | -187.86%-1.19B |
Gross dividend payment | ||||||||||
Basic earnings per share | -49.24%-16.7 | 21.97%112.74 | -0.27%77.38 | -1.71%33.28 | 288.76%13.27 | 6.67%-11.19 | 97.21%92.43 | 40.89%77.59 | 239.62%33.86 | -186.94%-7.03 |
Diluted earnings per share | -49.24%-16.7 | 21.97%112.74 | -0.27%77.38 | -1.72%33.2773 | 288.54%13.2678 | 6.67%-11.19 | 97.21%92.43 | 40.91%77.5896 | 239.68%33.86 | -187.23%-7.0372 |
Dividend per share | 0 | 27.78%23 | 27.78%23 | 0 | 0 | 0 | 50.00%18 | 50.00%18 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |